The DOI matches its Crossref record; 285 of the 285 references it cites were found in a registry or an index.
Epidemiology of Prostate Cancer
Open accessAbstract
Prostate cancer is the second most frequent cancer diagnosis made in men and the fifth leading cause of death worldwide. Prostate cancer may be asymptomatic at the early stage and often has an indolent course that may require only active surveillance. Based on GLOBOCAN 2018 estimates, 1,276,106 new cases of prostate cancer were reported worldwide in 2018, with higher prevalence in the developed countries. Differences in the incidence rates worldwide reflect differences in the use of diagnostic testing. Prostate cancer incidence and mortality rates are strongly related to the age with the highest incidence being seen in elderly men (> 65 years of age). African-American men have the highest incidence rates and more aggressive type of prostate cancer compared to White men. There is no evidence yet on how to prevent prostate cancer; however, it is possible to lower the risk by limiting high-fat foods, increasing the intake of vegetables and fruits and performing more exercise. Screening is highly recommended at age 45 for men with familial history and African-American men. Up-to-date statistics on prostate cancer occurrence and outcomes along with a better understanding of the etiology and causative risk factors are essential for the primary prevention of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–285 of 285
Price, A., Allen, N. E., Appleby, P. N., Crowe, F. L., Travis, R. C., Tipper, S. J., Overvad, K., Grønbæk, H., Tjønneland, A. M., Johnsen, N. F., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0481-t · Cited by 82
Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer
Chan, J. M., Oh, W. K., Xie, W., Regan, M. M., Stampfer, M. J., King, I. B., Abe, M., & Kantoff, P. W. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.8938 · Cited by 80
Prostate cancer prevention: Past, present, and future
Fleshner, N. E., & Zlotta, A. R. (2007) · Cancer · doi:10.1002/cncr.23009 · Cited by 79
Stram, D. O., Hankin, J. H., Wilkens, L. R., Park, S., Henderson, B. E., Nomura, A. M. Y., Pike, M. C., & Kolonel, L. N. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0064-0 · Cited by 79
Lippman, S. M., Klein, E. A., Goodman, P., Lucia, M. S., Thompson, I., Ford, L., Parnes, H., Minasian, L., Gaziano, J. M., Hartline, J. A., et al. (2009) · eScholarship (California Digital Library) · Cited by 78
Alcohol use and prostate cancer: A meta‐analysis
Fillmore, K. M., Chikritzhs, T. N., Stockwell, T. R., Bostrom, A., & Richard, P. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800122 · Cited by 77
Sutcliffe, S. (2010) · Future Oncology · doi:10.2217/fon.10.95 · Cited by 75
Diabetes Mellitus and Prostate Cancer Risk; A Nationwide Case–Control Study within PCBaSe Sweden
Fall, K., Garmo, H., Guðbjörnsdóttir, S., Stattin, P. E., & Zethelius, B. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1046 · Cited by 75
Platz, E. A., Leitzmann, M. F., Michaud, D. S., Willett, W. C., & Giovannucci, E. L. (2003) · PubMed · Cited by 75
Datta, M., & Schwartz, G. G. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0051 · Cited by 72
Epidemiological and Clinical Studies of Nutrition
Gibson, T. M., Ferrucci, L. M., Tangrea, J. A., & Schatzkin, A. G. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.05.011 · Cited by 71
Arthur, R., Møller, H., Garmo, H., Holmberg, L., Stattin, P. E., Malmström, H., Lambe, M. P., Hammar, N., Walldius, G., Robinson, D., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.665 · Cited by 71
Handayani, R., Rice, L. P., Cui, Y., Medrano, T. A., Samedi, V. G., Baker, H. V., Szabo, N. J., & Shiverick, K. T. (2006) · Journal of Nutrition · doi:10.1093/jn/136.1.75 · Cited by 70
Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer
Kraft, P. L., Pharoah, P. D. P., Chanock, S. J., Albanes, D., Kolonel, L. N., Hayes, R. B., Altshuler, D., Andriole, G. L., Berg, C. D., Boeing, H., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010068 · Cited by 70
Grant, W. B., & Peiris, A. N. (2012) · Dermato-Endocrinology · doi:10.4161/derm.19667 · Cited by 67
Klein, R. J., Halldén, C., Cronin, A. M., Ploner, A., Wiklund, F. E., Bjartell, A. S., Stattin, P. E., Xu, J., Scardino, P. T., Offit, K., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0206 · Cited by 66
Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer
Ryan, C. J., Haqq, C. M., Simko, J. P., et al. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2006.07.019 · Cited by 66
Freedland, S. J., & Aronson, W. J. (2005) · Urology · doi:10.1016/j.urology.2004.08.035 · Cited by 65
Okobia, M. N., Zmuda, J. M., Ferrell, R. E., Patrick, A. L., & Bunker, C. H. (2011) · The Prostate · doi:10.1002/pros.21320 · Cited by 65
Liu, X., Allen, J. D., Arnold, J. T., & Blackman, M. R. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn011 · Cited by 65
Hirayama, T. (1992) · PubMed · Cited by 65
Setlur, S. R., Chen, C. X., Hossain, R. R., Ha, J., Doren, V. V., Stenzel, B., Steiner, E., Oldridge, D. A., Kitabayashi, N., Banerjee, S., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1018 · Cited by 64
Camp, N. J., & Tavtigian, S. V. (2002) · The American Journal of Human Genetics · doi:10.1086/344516 · Cited by 61
Estrogen Receptor β Polymorphism Is Associated with Prostate Cancer Risk
Karlsson, C. T., Lindström, S., Malmer, B., Wiklund, F. E., Bälter, K. A., Adami, H., Stattin, P. E., Nilsson, M., Dahlman‐Wright, K., Gustafsson, J.-Α., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0269 · Cited by 60
Environmental exposures and prostate cancer
Mullins, J. K., & Loeb, S. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.11.014 · Cited by 59
Taneja, S. S., Morton, R., Barnette, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.7634 · Cited by 59
C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older
Pierce, B. L., Biggs, M. L., DeCambre, M. E., Reiner, A. P., Li, C., Fitzpatrick, A. L., Carlson, C. S., Stanford, J. L., & Austin, M. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9320-4 · Cited by 58
Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer
Ho, S., Rao, R., To, S. Q., Schoch, E., & Tarapore, P. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0175 · Cited by 58
Song, J., Kim, D. Y., Kim, C., Kim, H. J., Lee, D. H., Lee, H. M., Ko, W., & Lee, G. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.12.011 · Cited by 57
Agent Orange as a risk factor for high‐grade prostate cancer
Ansbaugh, N. J., Shannon, J., Mori, M., Farris, P. E., & Garzotto, M. G. (2013) · Cancer · doi:10.1002/cncr.27941 · Cited by 56
Noda, D., Itoh, S., Watanabe, Y., Inamitsu, M., Dennler, S., Itoh, F., Koike, S., Danielpour, D., ten Dijke, P., & Kato, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209571 · Cited by 56
Cytokine genetic polymorphisms and prostate cancer aggressiveness
Zabaleta, J., Su, L. J., Lin, H., Sierra, R. A., Hall, M. C., Sartor, O. A., Clark, P. E., Hu, J. J., & Ochoa, A. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp124 · Cited by 55
Molecular mechanisms involving prostate cancer racial disparity.
Karakaş, C., Wang, C., Deng, F., Huang, H., Wang, D., & Lee, P. (2017) · PubMed · Cited by 55
Margiotti, K., Kim, E. S., Pearce, C. L., Spera, E., Novelli, G., & Reichardt, J. K. V. (2002) · The Prostate · doi:10.1002/pros.10134 · Cited by 54
Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis
Lin, Y., Mao, Q., Zheng, X., Yang, K. G., Chen, H., Zhou, C., & Xie, L. (2011) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-011-0692-6 · Cited by 54
Loukola, A., Chadha, M., Penn, S. G., Rank, D. R., Conti, D. V., Thompson, D. J., Cicek, M. S., Love, B., Bivolarevic, V., Yang, Q., et al. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201101 · Cited by 53
Sartor, L., Pezzato, E., Donà, M., Dell’Aica, I., Calabrese, F., Morini, M., Albini, A., & Garbisa, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20496 · Cited by 52
Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate
Tomaszewski, J. J., Cummings, J. L., Parwani, A. V., Dhir, R., Mason, J. B., Nelson, J. B., Bacich, D. J., & O’Keefe, D. S. (2011) · The Prostate · doi:10.1002/pros.21346 · Cited by 52
Purification and characterization of chlordecone reductase from human liver.
Molowa, D. T., Shayne, A. G., & Guzelian, P. S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67136-4 · Cited by 51
Advances in mouse models of prostate cancer
Ahmad, I., Sansom, O. J., & Leung, H. Y. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000689 · Cited by 50
Morris, J. D. H., Pramanik, R., Zhang, X., Carey, A., Ragavan, N., MARTIN, F., & MUIR, G. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.037 · Cited by 50
Lindström, S., Wiklund, F., Adami, H., Bälter, K. A., Adolfsson, J., & Grönberg, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3024 · Cited by 48
Lehrer, S., Diamond, E. J., Stagger, S., Stone, N. N., & Stock, R. G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600526 · Cited by 48
Evidence for a Prostate Cancer Susceptibility Locus on the X Chromosome
Xu, J., Meyers, D. A., Freije, D., Isaacs, S. D., Wiley, K. E., Nusskern, D. R., Ewing, C. M., Wilkens, E. P., Bujnovszky, P., Bova, G. S., et al. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61689-6 · Cited by 46
Lloyd, J. C., Masko, E. M., Wu, C., et al. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2013.19 · Cited by 45
Disparities in prostate cancer in African American men: What primary care physicians can do
Wu, I., & Modlin, C. S. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.79a.11001 · Cited by 45
Vijayakumar, S., Kathryn Winter M.S., Sause, W. T., Michael J Gallagher M.D., Michalski, J. M., Roach, M., Porter, A. T., & Bondy, M. L. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00834-1 · Cited by 45
de Vogel, S., Meyer, K., Fredriksen, A., Ulvik, A., Ueland, P. M., Nygard, O. K., Vollset, S. E., Tell, G. S., Tretli, S., & Bjørge, T. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys199 · Cited by 45
Christensen, C. H., Platz, E. A., Andreotti, G., Blair, A. E., Hoppin, J. A., Koutros, S., Lynch, C. F., Sandler, D. P., & Alavanja, M. C. R. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800446 · Cited by 44
del Rosario, A. D., Bui, H. X., Abdulla, M., & Ross, J. S. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90210-8 · Cited by 44
Dietary intervention in the management of prostate cancer
Demark‐Wahnefried, W., & Moyad, M. A. (2007) · Current Opinion in Urology · doi:10.1097/mou.0b013e3280eb10fc · Cited by 44
TNF polymorphisms and prostate cancer risk
Danforth, K. N., Rodríguez, C., Hayes, R. B., Sakoda, L. C., Huang, W., Yu, K. F., Calle, E. E., Jacobs, E. J., Chen, B. E., Andriole, G. L., et al. (2008) · The Prostate · doi:10.1002/pros.20694 · Cited by 43
Molecular mechanisms involving prostate cancer racial disparity.
Hatcher, D. M., Daniels, G., Osman, I., & Lee, P. (2009) · PubMed · Cited by 42
Dietary Folate Deficiency Blocks Prostate Cancer Progression in the TRAMP Model
Bistulfi, G. L., Foster, B. A., Karasik, E., Gillard, B. M., Miecznikowski, J. C., Dhiman, V. K., & Smiraglia, D. J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0140 · Cited by 42
Diagnostic radiation procedures and risk of prostate cancer
Myles, P. R., Evans, S., Lophatananon, A., Dimitropoulou, P., Easton, D. F., Key, T. J., Pocock, R., Dearnaley, D. P., Guy, M., Edwards, S. E., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604370 · Cited by 41
Obesity, Endogenous Hormone Metabolism, and Prostate Cancer Risk: A Conundrum of “Highs” and “Lows”
Kaaks, R., & Stattin, P. E. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0014 · Cited by 41
Bhatia, V., Saini, M. K., Shen, X., Bi, L. X., Qiu, S., Weigel, N. L., & Falzon, M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0064 · Cited by 38
Obesity and Prostate Cancer Detection: Insights from Three National Surveys
Parekh, N., Lin, Y., DiPaola, R. S., Marcella, S., & Lu‐Yao, G. L. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.05.011 · Cited by 38
One-carbon metabolism-related nutrients and prostate cancer survival
Kasperzyk, J. L., Fall, K., Mucci, L. A., Håkansson, N., Wolk, A., Johansson, J., Andersson, S., & Andrén, O. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27645 · Cited by 37
Petersen, L. F., Brockton, N. T., Bakkar, A., Liu, S., Wen, J., Weljie, A. M., & Bismar, T. A. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10437.x · Cited by 36
Chen, Y., Kraft, P. L., Bretsky, P. M., Ketkar, S., Hunt, S. E., Albanes, D., Altshuler, D., Andriole, G., Berg, C. D., Boeing, H., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0431 · Cited by 31
Association Between Smoking Status, and Free, Total and Percent Free Prostate Specific Antigen
Li, J., Thompson, T., Joseph, D. A., & Master, V. A. (2012) · The Journal of Urology · doi:10.1016/j.juro.2011.11.086 · Cited by 31
Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer
Kang, J., Chen, M., Zhang, Y., Moran, B. J., Dosoretz, D. E., Katin, M. J., Braccioforte, M. H., Salenius, S. A., & D'Amico, A. V. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.07.003 · Cited by 31
Lycopene and beta-carotene ameliorate catechol estrogen-mediated DNA damage.
Muzandu, K. M., Bohi, K. E., Shaban, Z., Ishizuka, M., Kazusaka, A., & Fujita, S. (2005) · PubMed · doi:10.14943/jjvr.52.4.173 · Cited by 31
EphB2 SNPs and Sporadic Prostate Cancer Risk in African American Men
Robbins, C. M., Hooker, S. E., Kittles, R. A., & Carpten, J. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019494 · Cited by 29
Major, J. M., Cross, A. J., Watters, J. L., Hollenbeck, A. R., Graubard, B. I., & Sinha, R. R. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9845-1 · Cited by 29
Stanford, J. L., FitzGerald, L. M., McDonnell, S. K., Carlson, E. E., McIntosh, L. M., Deutsch, K., Hood, L., Ostrander, E. A., & Schaid, D. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp100 · Cited by 28
Danforth, K. N., Hayes, R. B., Rodríguez, C., Yu, K., Sakoda, L. C., Huang, W., Chen, B. E., Chen, J., Andriole, G. L., Calle, E. E., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm253 · Cited by 28
Kume, T., Iwasa, H., Shiraishi, H., Yokoi, T., Nagashima, K., Otsuka, M., Terada, T., Takagi, T., Hara, A., & Kamataki, T. (1999) · Pharmacogenetics · doi:10.1097/00008571-199912000-00011 · Cited by 27
Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer
Chang, B., Zheng, S. L., Isaacs, S. D., et al. (2003) · The Prostate · doi:10.1002/pros.10225 · Cited by 27
Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study
Papa, N. P., MacInnis, R. J., English, D. R., Bolton, D. M., Davis, I. D., Lawrentschuk, N., Millar, J. L., Pedersen, J., Severi, G., Southey, M. C., et al. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.03.007 · Cited by 27
Ku, J. H., Jeong, C. W., Park, Y. H., Cho, M., Kwak, C. H., & Kim, H. H. (2010) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2010.39 · Cited by 26
Traditional androgen ablation approaches to advanced prostate cancer: new insights.
Rove, K. O., & Crawford, E. D. (2014) · PubMed · Cited by 25
COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men
Fernandez, P., de Beer, P. M., van der Merwe, L., & Heyns, C. F. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn245 · Cited by 25
Estimating bisphenol A exposure levels using a questionnaire targeting known sources of exposure
Nomura, S. O., Harnack, L., & Robien, K. (2015) · Public Health Nutrition · doi:10.1017/s1368980015002116 · Cited by 25
Drug Insight: lycopene in the prevention and treatment of prostate cancer
Guns, E. S. T., & Cowell, S. P. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0073 · Cited by 24
Alcohol consumption and prostate cancer: a mini review.
Rizos, C., Papassava, M., Ch, G., & Charalabopoulos, K. (2010) · PubMed · Cited by 23
Constitutional risk factors in prostate cancer
Ferrís-i-Tortajada, J., García-i-Castell, J., Berbel‐Tornero, O., & Ortega-García, J. A. (2011) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2011.06.005 · Cited by 23
Drug-Diagnostics Co-Development in Oncology
Simon, R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00315 · Cited by 23
5α-Reductase inhibitor treatment of prostatic diseases: background and practical implications
Dorsam, J., & Altwein, J. E. (2008) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2008.56 · Cited by 18
Tomaszewski, J. J., Richman, E. L., Sadetsky, N., O’Keefe, D. S., Carroll, P. R., Davies, B. J., & Chan, J. M. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.09.065 · Cited by 17
Inflammation and Infection in the Etiology of Prostate Cancer
Sutcliffe, S., & Pontari, M. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800077-9.00002-5 · Cited by 14
Genetic variation in the HSD17B1 gene and risk of prostate cancer
Kraft, P. L., Hayes, R. B., Pharoah, P. D. P., Chanock, S. J., Albanes, D., Kolonel, L. N., Altshuler, D., Andriole, G. L., Berg, C., Boeing, H., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010068.eor · Cited by 14
Suzuki, M., Muto, S., Hara, K., Ozeki, T., Yamada, Y., Kadowaki, T., Tomita, K., Kameyama, S., & Kitamura, T. (2005) · International Journal of Urology · doi:10.1111/j.1442-2042.2005.01004.x · Cited by 7
Sharma, N., Sood, S., Kaushik, G. G., & Ali, Z. (2013) · International Journal of Research in Medical Sciences · doi:10.5455/2320-6012.ijrms20131132 · Cited by 3
Cited by
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., & Mashele, S. (2022) · Molecules · doi:10.3390/molecules27175730 · Cited by 904
Kombe Kombe, A. J., Li, B., Zahid, A., Mengist, H. M., Bounda, G.-A., Zhou, Y., & Jin, T. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2020.552028 · Cited by 646
Epidemiology and Prevention of Prostate Cancer
Gandaglia, G., Leni, R., Bray, F., Fleshner, N., Freedland, S. J., Kibel, A., Stattin, P., Van Poppel, H., & La Vecchia, C. (2021) · European Urology Oncology · doi:10.1016/j.euo.2021.09.006 · Cited by 611
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 607
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
Metadata
- Authors
- Rawla, P.
- Venue
- World Journal of Oncology
- Publisher
- Elmer Press, Inc.
- Published
- 2019
- Volume
- 10
- Issue
- 2
- Pages
- 63-89
- ISSN
- 1920-4531 (ISSN-L)
- 1920-454X
- OpenAlex
- W2937483840
- Cited by
- 2,776
- References
- 285
- FWCI
- 195.03
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.